Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2008 1
2009 2
2010 1
2011 3
2012 4
2013 1
2014 3
2015 5
2016 7
2017 5
2018 3
2019 11
2020 6
2021 5
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Anticancer Inhibitors.
Ammazzalorso A, Fantacuzzi M. Ammazzalorso A, et al. Molecules. 2022 Jul 21;27(14):4650. doi: 10.3390/molecules27144650. Molecules. 2022. PMID: 35889522 Free PMC article.
Anticancer Activity of Stilbene-Based Derivatives.
De Filippis B, Ammazzalorso A, Fantacuzzi M, Giampietro L, Maccallini C, Amoroso R. De Filippis B, et al. Among authors: ammazzalorso a. ChemMedChem. 2017 Apr 20;12(8):558-570. doi: 10.1002/cmdc.201700045. Epub 2017 Mar 28. ChemMedChem. 2017. PMID: 28266812 Review.
Anticancer Activity of Natural Products and Related Compounds.
De Filippis B, Fantacuzzi M, Ammazzalorso A. De Filippis B, et al. Among authors: ammazzalorso a. Int J Mol Sci. 2023 Nov 20;24(22):16507. doi: 10.3390/ijms242216507. Int J Mol Sci. 2023. PMID: 38003697 Free PMC article.
Development of CDK4/6 Inhibitors: A Five Years Update.
Ammazzalorso A, Agamennone M, De Filippis B, Fantacuzzi M. Ammazzalorso A, et al. Molecules. 2021 Mar 9;26(5):1488. doi: 10.3390/molecules26051488. Molecules. 2021. PMID: 33803309 Free PMC article. Review.
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer.
Maccallini C, Ammazzalorso A, De Filippis B, Fantacuzzi M, Giampietro L, Amoroso R. Maccallini C, et al. Among authors: ammazzalorso a. Pharmaceuticals (Basel). 2022 May 26;15(6):667. doi: 10.3390/ph15060667. Pharmaceuticals (Basel). 2022. PMID: 35745586 Free PMC article. Review.
67 results